Detalles de la búsqueda
1.
Estimating Post-treatment Recurrence After Multidrug-Resistant Tuberculosis Treatment Among Patients With and Without Human Immunodeficiency Virus: The Impact of Assumptions About Death and Missing Follow-up.
Clin Infect Dis
; 78(1): 164-171, 2024 01 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37773767
2.
Undernutrition as a risk factor for tuberculosis disease.
Cochrane Database Syst Rev
; 6: CD015890, 2024 06 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38860538
3.
Effectiveness of Bedaquiline Use beyond Six Months in Patients with Multidrug-Resistant Tuberculosis.
Am J Respir Crit Care Med
; 207(11): 1525-1532, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36802336
4.
Effect of large-scale mass drug administration for malaria on mortality and morbidity in Angumu health zone, Ituri, Democratic Republic of Congo.
Malar J
; 22(1): 44, 2023 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36747229
5.
Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort.
Clin Infect Dis
; 75(6): 1006-1013, 2022 09 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35028659
6.
Safety and Effectiveness Outcomes From a 14-Country Cohort of Patients With Multi-Drug Resistant Tuberculosis Treated Concomitantly With Bedaquiline, Delamanid, and Other Second-Line Drugs.
Clin Infect Dis
; 75(8): 1307-1314, 2022 10 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35243494
7.
All-oral longer regimens are effective for the management of multidrug-resistant tuberculosis in high-burden settings.
Eur Respir J
; 59(1)2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34140298
8.
Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid. A Prospective Multicountry Study.
Am J Respir Crit Care Med
; 203(1): 111-119, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32706644
9.
Culture Conversion at 6 Months in Patients Receiving Delamanid-containing Regimens for the Treatment of Multidrug-resistant Tuberculosis.
Clin Infect Dis
; 71(2): 415-418, 2020 07 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31676905
10.
Treatment Outcomes of Patients Switching From an Injectable Drug to Bedaquiline During Short Standardized Treatment for Multidrug-resistant Tuberculosis in Mozambique.
Clin Infect Dis
; 69(10): 1809-1811, 2019 10 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-30901021
11.
Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis.
Emerg Infect Dis
; 25(5): 936-943, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31002070
12.
Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/µl in 2 low-resource settings: A prospective observational study.
PLoS Med
; 16(4): e1002792, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31039161
13.
Mortality in the first six months among HIV-positive and HIV-negative patients empirically treated for tuberculosis.
BMC Infect Dis
; 19(1): 132, 2019 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30744603
14.
The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens.
BMC Infect Dis
; 19(1): 733, 2019 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31429722
15.
Xpert MTB/RIF diagnosis of childhood tuberculosis from sputum and stool samples in a high TB-HIV-prevalent setting.
Eur J Clin Microbiol Infect Dis
; 37(8): 1465-1473, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29740714
16.
Performance and time to become negative after treatment of three malaria rapid diagnostic tests in low and high malaria transmission settings.
Malar J
; 15(1): 496, 2016 10 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27716244
17.
Effects of treatment interruption patterns on treatment success among patients with multidrug-resistant tuberculosis in Armenia and Abkhazia.
J Infect Dis
; 211(10): 1607-15, 2015 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25312040
18.
Impact of variability in adherence to HIV antiretroviral therapy on the immunovirological response and mortality.
BMC Med Res Methodol
; 15: 10, 2015 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-25656082
19.
Bedaquiline and Repurposed Drugs for Fluoroquinolone-Resistant Multidrug-Resistant Tuberculosis: How Much Better Are They?
Am J Respir Crit Care Med
; 198(9): 1228-1231, 2018 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29969054
20.
Case fatality risk among individuals vaccinated with rVSVΔG-ZEBOV-GP: a retrospective cohort analysis of patients with confirmed Ebola virus disease in the Democratic Republic of the Congo.
Lancet Infect Dis
; 24(6): 602-610, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38340736